Neuropilin-1 is a marker of poor prognosis in early breast cancer
Neuropilin-1 (NRP1) is an essential cell surface receptor with an established role in development and immunity. Due to alternative splicing or shedding, the extracellular region can be released into circulation as soluble Neuropilin-1 (sNRP1). Researchers in Germany have shown that sNRP1 is an independent prognostic marker for breast cancer-specific survival. The study included 506 patients diagnosed with primary, non-metastatic breast cancer.
Read the full article here: https://buff.ly/3uvOBuh
Soluble NRP1 was measured with Biomedica´s ELISA kit.: https://buff.ly/38HbbWI
Features & Benefits
√ Low sample volume – only 10 µl required
√ Ready to use calibrators and controls
√ Full VALIDATION package
√ HIGH QUALITY GUARANTEED
Find out more: https://buff.ly/2oXzsWh